Brick & Kyle Associates
BMY icon

Brick & Kyle Associates’s Bristol-Myers Squibb BMY Stock Holding History

Brick & Kyle Associates’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-20,796
Closed -$1.26M – 68
2026
Q2 		$1.26M Hold
20,796
– – 0.42% 44
2026
Q1 		$1.26M Buy
+20,796
New +$1.21M 0.42% 44
2019
Q1 		– Sell
-37,957
Closed -$1.97M – 67
2018
Q4 		$1.97M Buy
+37,957
New +$2.04M 1.89% 19
2018
Q2 		$2.23M Sell
40,369
-12,692
-24% -$685K 1.75% 22
2018
Q1 		$3.36M Sell
53,061
-592
-1% -$38.1K 2.71% 8
2017
Q4 		$3.29M Sell
53,653
-268
-0.5% -$16.8K 2.67% 10
2017
Q3 		$3.44M Buy
53,921
+62
+0.1% +$3.62K 2.78% 8
2017
Q2 		$3M Sell
53,859
-3,316
-6% -$180K 2.58% 13
2017
Q1 		$3.11M Sell
57,175
-4,028
-7% -$221K 2.41% 9
2016
Q4 		$3.58M Buy
61,203
+2,029
+3% +$111K 2.87% 2
2016
Q3 		$3.19M Buy
59,174
+741
+1% +$47.6K 2.57% 4
2016
Q2 		$4.3M Buy
58,433
+1,020
+2% +$72.1K 3.52% 1
2016
Q1 		$3.67M Buy
57,413
+146
+0.3% +$9.21K 3.18% 2
2015
Q4 		$3.94M Buy
57,267
+5,083
+10% +$336K 3.47% 2
2015
Q3 		$3.09M Buy
52,184
+1,978
+4% +$125K 2.9% 3
2015
Q2 		$3.34M Buy
50,206
+1,798
+4% +$118K 2.8% 4
2015
Q1 		$3.12M Buy
48,408
+2,240
+5% +$140K 2.67% 5
2014
Q4 		$2.72M Buy
+46,168
New +$2.6M 2.35% 7

Other funds holding BMY

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Independent Franchise Partners
Independent Franchise Partners London, United Kingdom $16.1B AUM 4.39% 1-Year Est. Return

Brick & Kyle Associates's BMY Position: Q3 2026 in Review

Brick & Kyle Associates sold out of Bristol-Myers Squibb (BMY) in Q3 2026, closing a stake of 20,796 shares — an estimated $1.26M sold.

Brick & Kyle Associates first reported a position in BMY in Q4 2014 and held it in 18 quarters. The position peaked at $4.3M in Q2 2016. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Brick & Kyle Associates reported no remaining Bristol-Myers Squibb position as of Q3 2026 after selling out during the quarter.
  • Brick & Kyle Associates sold 20,796 Bristol-Myers Squibb shares in Q3 2026, an estimated $1.26M.
  • Brick & Kyle Associates first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 18 quarters.
  • Brick & Kyle Associates's Bristol-Myers Squibb position peaked at $4.3M in Q2 2016.
  • 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Brick & Kyle Associates's 13F filing for Q3 2026, filed 5 Nov 2026.